On the afternoon of September 25, 37 experts from the flight inspection team of the National Health Insurance Administration were stationed in Wuxi Hongqiao Hospital to conduct professional verification of the hospital's massive diagnosis and treatment data.

Zhu Chenggang, a radiographer at the hospital, said that since last year, there have been some patient medical records in the hospital system who have not done imaging examinations in their department at all, and they have neither taken films in the hospital, nor have the imaging numbers filed by the radiology department, but the medical records have "diagnoses made based on images".

On September 23, the National Health Insurance Bureau sent a flight inspection team to Wuxi Hongqiao Hospital to carry out a special flight inspection, and at the same time, the National Health Insurance Bureau guided the Jiangsu Provincial Health Insurance Bureau to send 20 inspection teams to all districts and counties under the jurisdiction of Wuxi City to carry out a comprehensive inspection of more than 100 designated medical institutions. The local public security organs have filed a case for investigation, and the relevant personnel of the hospital have been controlled, and will be seriously dealt with in accordance with the law.

The official website of Wuxi Hongqiao Hospital cannot be opened at present, and the official website previously showed that the hospital is a second-class general hospital, with a construction area of more than 20,000 square meters and 160 beds, which is a designated unit of medical insurance in Wuxi.

After the equity penetration of Wuxi Hongqiao Hospital, a number of important figures in the Putian department flashed among them.

The founder of many companies is riddled with negative news

The largest shareholder of Wuxi Hongqiao Hospital is Shanghai Medea Hospital Investment Group Co., Ltd. (hereinafter referred to as "Medea Investment"), holding 40% of the shares; the third largest shareholder, Zhejiang Media Hospital Investment Management Co., Ltd., with a shareholding ratio of 17.5%; Among the historical shareholders, two brothers, Chen Guoxing and Chen Guoxiong, withdrew from the list of directors in 2020 and 2017 respectively. In 2020, Wang Weimin took over as chairman and legal representative. The first financial reporter is currently unable to confirm the relationship between Wang Weimin and Chen.

In the early days, Medea Investment was funded by the Chen brothers and another natural person, Zhan Yan. According to the external information of Medea Investment, Medea Hospital Group has set up large-scale medical institutions in Shanghai, Hangzhou, Shenzhen, Wuhan, Changsha, Wuxi, Kunshan, Wenzhou, Ningbo, Henan Xinzheng and other places, and has more than 30 hospitals, including Shanghai Hongqiao Hospital, Shanghai Jianqiao Hospital, Shanghai New Hongqiao Hospital, Kunshan Hongqiao Hospital, Wuxi Hongqiao Hospital, Hangzhou Hongqiao Hospital, Hangzhou Tianmushan Hospital, Shenzhen Jianguo Urology Hospital, etc.

Chen Guoxing and Chen Guoxiong also have actual control over Yixing Medical Beauty Group Co., Ltd. (hereinafter referred to as "Yixing Medical Beauty"), with Chen Guoxing as the legal representative and chairman of the board of directors, and Chen Guoxiong as the vice chairman. In 2018, Yixing Medical Aesthetics submitted to the Hong Kong Stock Exchange, at that time, Yixing Medical Aesthetics owned and operated 15 medical aesthetic institutions in 14 major cities across the country. In 2019, Yixing Medical Aesthetics withdrew its listing materials.

Yixing Medical Aesthetics is also riddled with negative news, the most sensational is that in July 2019, a Dalian woman underwent breast augmentation surgery in her hospital and died during the operation. According to the medical malpractice technical appraisal issued by the Dalian Medical Association, this case is a first-class medical malpractice, and the doctor bears full responsibility.

Chen Guoxing was also the initial major shareholder of Yixin Financial Information Service (Shanghai) Co., Ltd., the company's "Medical Loan", the first P2P platform in China focusing on lending services for the medical industry.

In addition, the actual controller of Shanghai Fuyi Venture Capital Co., Ltd., the second largest shareholder of Wuxi Hongqiao Hospital, is Lin Mingxiong, and Xuzhou Jiulong Maternity Hospital, of which Lin Mingxiong is a director, was reported by the media as a Putian hospital, and the hospital will be fined for unauthorized injection of hyaluronic acid in 2023.

The partner was fined 140 million for insurance fraud

Chen Guoxing took a stake in Medicilon (688202. SH), which is engaged in drug discovery and pharmaceutical research and preclinical research CRO services. On September 26, Medicilon closed at 27.01 yuan per share, with a total market value of 3.639 billion yuan.

As of the end of June this year, Chen Guoxing was the company's sixth largest shareholder. According to Medicilon's disclosure, Chen Guoxing was born in January 1971, Chinese nationality, permanent residency in the Republic of Vanuatu, and a master's degree candidate. From July 2003 to December 2020, he founded Medea Investment and served as an executive director; Since March 2011, he has served as the chairman of Yixing Medical Beauty Group Co., Ltd.; He has successively served as the "First Honorary President of Shanghai Medical and Health Association", "Vice President of Shanghai Association of Social Medical Institutions" and "Vice President of the 8th Council of Shanghai Fujian Chamber of Commerce".

Extended by Chen Guoxing is the territory of the Chen family of Putian medical treatment. ACCORDING TO THE MEDISILON PROSPECTUS, SHAREHOLDER CHEN JINZHANG IS THE COUSIN OF CHUN-LIN CHEN, THE COUSIN OF SHAREHOLDER CHEN CHUNLAI, THE UNCLE OF SHAREHOLDER CHEN GUOXING, THE FATHER-IN-LAW OF SHAREHOLDER LIN CHANGQING AND THE BROTHER-IN-LAW OF SHAREHOLDER ZHANG ZONGBAO.

At the time of the issuance of the prospectus, Medicilon was jointly and effectively controlled by Chen Chunlin, Chen Jinzhang and Chen Jianhuang, and signed a concerted action agreement. Chen Jianhuang is currently the second largest shareholder of Medicilon, and he is an important figure in Putian's medical industry. In 1995, Chen Jianhuang invested more than 10 million yuan to establish Jinan Huaxia Hospital, creating a precedent for private hospitals in China. A number of private hospitals with names such as "Huaxia" and "Huakang", as well as the more well-known Beijing Qianhai Femoral Head Hospital, are controlled by him. It is worth mentioning that according to the announcement on the website of the Beijing Municipal Medical Security Bureau in 2022, Qianhai Femoral Head Hospital was fined 142 million yuan for fraud, falsification of supporting materials or other means to defraud the expenditure of the social insurance fund.

(This article is from Yicai).

View original image 3.17M